‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
The Beacon
What does the CheckMate-331 trial of nivolumab vs. chemo for relapsed SCLC tell us? (BMIC-072)
30
00:00:00
/ 00:08:58
30